For example, whilst insulin-sensitizing treatments other than metformin (such as myoinositol and d-chiro-inositol) are widely used, they remain understudied in women with PCOS, whilst the role of metformin itself in GnRH antagonist or PPOS cycles is also uncertain. Here, GNRH1 is linked to polycystic ovary syndrome.